Acorah Software Products - Accounts Production 15.0.600 false true 31 March 2023 1 April 2022 false true No description of principal activity 1 April 2023 31 March 2024 31 March 2024 08930794 Dr Peter Concannon Dr Laura Concannon iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 08930794 2023-03-31 08930794 2024-03-31 08930794 2023-04-01 2024-03-31 08930794 frs-core:CurrentFinancialInstruments 2024-03-31 08930794 frs-core:Non-currentFinancialInstruments 2024-03-31 08930794 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 08930794 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 08930794 frs-bus:Micro-entities 2023-04-01 2024-03-31 08930794 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 08930794 frs-bus:Director1 2023-04-01 2024-03-31 08930794 frs-bus:Director1 2023-03-31 08930794 frs-bus:Director1 2024-03-31 08930794 frs-bus:Director2 2023-04-01 2024-03-31 08930794 2022-03-31 08930794 2023-03-31 08930794 2022-04-01 2023-03-31 08930794 frs-core:CurrentFinancialInstruments 2023-03-31 08930794 frs-core:Non-currentFinancialInstruments 2023-03-31
Registered number: 08930794
Concannon Medical Limited
Unaudited Financial Statements
For The Year Ended 31 March 2024
Balance Sheet
Registered number: 08930794
2024 2023
£ £
Fixed assets 2,740 3,465
Current assets 51,459 52,544
Prepayments and accrued income 209 -
Creditors: Amounts Falling Due Within One Year (16,478 ) (17,283 )
NET CURRENT ASSETS 35,190 35,261
TOTAL ASSETS LESS CURRENT LIABILITIES 37,930 38,726
Creditors: Amounts Falling After More Than One Year (6,605 ) (10,325 )
Accruals and deferred income (1,248 ) (1,248 )
NET ASSETS 30,077 27,153
CAPITAL AND RESERVES 30,077 27,153

Notes

1. General Information
Concannon Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 08930794 . The registered office is First Floor, Unit 12, Compass Point, Ensign Way, Hamble, Southampton, Hampshire, SO31 4RA.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 2)
2 2
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 April 2023 Amounts advanced Amounts repaid Amounts written off As at 31 March 2024
£ £ £ £ £
Dr Peter Concannon 39,208 34,600 48,738 - 25,070
The above loan is unsecured, interest bearing at a rate of 2.25% p.a. and repayable on demand. Interest charged for the year was £715 (2023: £1,506).
Page 0
Page 1
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Peter Concannon
Director
29th July 2024